Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07648771 · ClinicalTrials.gov registry record
Outcomes Registry After Ketamine Infusions for Chronic Pain: A Longitudinal Evaluation
A clinical trial, sponsored by Stanford University.
- Not yet
- Registry status
- 800
- Enrollment target
NCT07648771: Clinical Trial study, sponsored by Stanford University.
NCT07648771 is a clinical trial that has not yet begun recruiting, run by Stanford University. The registered enrollment target is 800 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07648771 has not yet begun recruiting, sponsored by Stanford University.
- NOT YET RECRUITING
- Registry status
- 800 participants
- Enrollment target
Study Summary
Ketamine is an anesthetic drug that is sometimes used to relieve chronic pain. The goal of this observational study is to learn about how patients respond to ketamine infusions for chronic pain. Note: This study does not provide ketamine - instead, this study uses surveys to follow patients who are already scheduled to receive ketamine infusions as part of their regular medical care. We will also follow a second group of patients who were recommended ketamine infusions by their doctor but were denied insurance coverage for this treatment. These participants will complete the same surveys for up to 16 weeks, starting from when their treatment was originally scheduled. Comparing this group to patients who received ketamine will help researchers better understand ketamine's effects and how insurance denials affect chronic pain patients.
Interventions
- DRUG Ketamine (Ketalar)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2026-08 |
| Est. Completion | 2034-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07648771
The ClinicalTrials.gov registry entry for NCT07648771 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 800 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ketamine (Ketalar) is the first listed.
NCT07648771 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07648771 about?
NCT07648771 is a clinical study titled "Outcomes Registry After Ketamine Infusions for Chronic Pain: A Longitudinal Evaluation". Ketamine is an anesthetic drug that is sometimes used to relieve chronic pain. The goal of this observational study is to learn about how patients respond to ketamine infusions for chronic pain. Note: This study does not provide ketamine - instead, this study uses surveys to follow patients who are...
What is the current status of trial NCT07648771?
This trial is currently not yet recruiting. The enrollment target is 800 participants. The study started on 2026-08. Estimated completion is 2034-12.
What interventions are being tested in trial NCT07648771?
The interventions under investigation include: Ketamine (Ketalar) (DRUG).
Who is sponsoring clinical trial NCT07648771?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.